Joseph Carleone
CIK 1212515 · CEO & President · last filed 2026-07-01
Joseph Carleone is a CEO & President who has filed 93 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for SXT, was dated Jul 1, 2026. Across all open-market trades the lifetime net is +$733.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.20M
4
93
$733.8K
Filer Profile
SUITE 700
LAS VEGAS, NV 89169
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SXT | Director | 23,735 | $134.84 | $3.20M | $342.5K | 64 | 2026-07-01 |
| Avid Bioservices, Inc. (CDMO) Delisted | Director | 130,324 | $12.49 | $1.63M | $190.7K | 5 | 2024-12-17 |
| Avid Bioservices, Inc. (CDMOP) Delisted | Director | 66,945 | $25.06 | $1.68M | $200.6K | 6 | 2020-12-16 |
| Avid Bioservices, Inc. (PPHMP) Delisted | Director | — | — | — | $0 | 1 | 2017-11-29 |
Recent Filings
93 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | SXT | Grant (A) | — | $0 | EDGAR |
| 2026-04-27 | SXT | Grant (A) | +1,119 | $0 | EDGAR |
| 2026-04-01 | SXT | Grant (A) | — | $0 | EDGAR |
| 2026-01-02 | SXT | Grant (A) | — | $0 | EDGAR |
| 2025-11-03 | SXT | Buy (P) | +1,000 | $91.3K | EDGAR |
| 2025-10-01 | SXT | Grant (A) | — | $0 | EDGAR |
| 2025-07-01 | SXT | Grant (A) | — | $0 | EDGAR |
| 2025-04-28 | SXT | Grant (A) | +1,386 | $0 | EDGAR |
| 2025-04-01 | SXT | Grant (A) | — | $0 | EDGAR |
| 2025-02-07 | — | Disp (D) | −130,324 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.